Burkina Faso vs Cabo Verde: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Burkina Faso
0.7%
in 2024
Cabo Verde
0.7%
in 2024
Burkina Faso rank
51st
Cabo Verde rank
51st
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Burkina Faso
- Cabo Verde
How they compare
Burkina Faso currently reports 0.7% against 0.7% in Cabo Verde, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Cabo Verde ahead.
Burkina Faso ranks 51st and Cabo Verde ranks 51st of 246 countries.
Burkina Faso has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Cabo Verde | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 0.8% | 0.1% | Burkina Faso |
| 2020s | 0.8% | 0.6% | 0.2% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Burkina Faso or Cabo Verde?
- Burkina Faso, at 0.7% against 0.7% in Cabo Verde as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Burkina Faso and Cabo Verde?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Cabo Verde?
- 10 years are reported by both, from 2015 to 2024.
- How do Burkina Faso and Cabo Verde rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Burkina Faso ranks 51st and Cabo Verde ranks 51st of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.